<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Up to 35% of patients undergoing optic nerve sheath decompression (ONSD) for <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> who show initial improvement in visual function later show deterioration in visual field and acuity </plain></SENT>
<SENT sid="1" pm="."><plain>Although repeat surgery can result in subsequent visual improvement, these procedures are technically difficult because of <z:hpo ids='HP_0100699'>scarring</z:hpo> and <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Attempting to improve the long-term success of ONSD, the authors sought to analyze the long-term success of ONSD by pretreating optic nerve sheaths with <z:chebi fb="0" ids="27504">mitomycin C</z:chebi> before incision </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Using a standard transconjunctival medial orbitotomy, optic nerve sheaths were exposed and treated for 5 minutes with <z:chebi fb="0" ids="27504">mitomycin C</z:chebi> (0.5 mg/ml)-soaked neurosurgical cottonoids before incision </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Both eyes undergoing repeat ONSD with adjunctive <z:chebi fb="0" ids="27504">mitomycin C</z:chebi> had initial improvement and stable visual function for follow-up of more than 3 years </plain></SENT>
<SENT sid="5" pm="."><plain>Four eyes that underwent primary ONSD <z:hpo ids='HP_0000001'>all</z:hpo> initially showed improvement in visual field </plain></SENT>
<SENT sid="6" pm="."><plain>Three eyes with large <z:mpath ids='MPATH_62'>cysts</z:mpath> or <z:mpath ids='MPATH_70'>fistulas</z:mpath> remained stable </plain></SENT>
<SENT sid="7" pm="."><plain>Another eye had gradual decline in visual function </plain></SENT>
<SENT sid="8" pm="."><plain>Repeat ONSD in this eye showed no orbital <z:hpo ids='HP_0100699'>scarring</z:hpo>, and lysis of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesions</z:e> between dura-arachnoid and optic nerve resulted in improved, stable visual function for 31 months of follow-up </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: <z:chebi fb="0" ids="27504">Mitomycin C</z:chebi> appears to be a safe adjunct to ONSD in a series of six patients followed between 20 and 37 months </plain></SENT>
<SENT sid="10" pm="."><plain>Fistulization and <z:mpath ids='MPATH_62'>cyst</z:mpath> formation are associated with improved visual function </plain></SENT>
<SENT sid="11" pm="."><plain>Closure of <z:mpath ids='MPATH_62'>cysts</z:mpath> and <z:mpath ids='MPATH_70'>fistulas</z:mpath> may result in worsening visual function due to intersheath <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesions</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Repeat surgery shows significantly less orbital <z:hpo ids='HP_0100699'>scarring</z:hpo> and allows for easier and successful repeat surgery </plain></SENT>
<SENT sid="13" pm="."><plain>Adjunctive <z:chebi fb="0" ids="27504">mitomycin C</z:chebi> leads to less orbital <z:hpo ids='HP_0100699'>scarring</z:hpo> after ONSD, allowing for easier repeat surgery </plain></SENT>
</text></document>